Atlas Trials

Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation

Clinical trial NCT02957552 · UNKNOWN

Trial details

NCT number
NCT02957552
Sponsor
University Hospital Tuebingen
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Pediatric Liver Transplantation
Start date
2017-03-10
Primary completion
2019-12-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.